Circular Knotted Peptides From Plants: Antimicrobial Activity and Structure-Activity Rules | Research

The takeaway

Four macrocyclic cystine-knot peptides from plants showed antimicrobial activity, and synthetic analogs revealed that the intact circular backbone and disulfide knot are essential for both structure and bioactivity.

Both features required
Neither the circular backbone alone nor the disulfide bonds alone are sufficient — both must be intact for cyclotide structure and antimicrobial activity

What the researchers found

Macrocyclic cystine-knot peptides showed antimicrobial activity requiring both the intact circular backbone and disulfide knot; disrupting either eliminated structure and biological activity.

Why it matters

Knowing which structural features are essential for cyclotide activity guides drug design. The requirement for both circular backbone and knotted disulfides confirms the extraordinary stability is directly linked to biological function.

How the study worked

In-vitro study testing 4 natural macrocyclic peptides and 10 synthetic analogs against bacteria and fungi. Structural requirements assessed by systematically disrupting backbone cyclization and disulfide bonds.

What this study cannot tell us

Limited antimicrobial spectrum tested. The physiological function of these peptides in plants remains undetermined. Synthetic modifications were limited to backbone and disulfide disruptions.

How to read the evidence

Moderate evidence from a systematic structure-activity study using natural and synthetic peptides, providing clear design rules.

When this study was published

Published in 1999. Cyclotide drug design has advanced significantly, with the structure-activity rules described here guiding scaffold engineering efforts.

The bigger picture

Cyclotides' integrated structure-function relationship makes them ideal drug scaffolds. The stability comes from the same features that enable activity, meaning engineered cyclotides will inherit both properties automatically.

Questions still open

Can active sequences from other drugs be grafted into the cyclotide scaffold?
What is the mechanism of cyclotide antimicrobial action?
Can cyclotides be produced at scale for pharmaceutical use?

Common questions

What makes cyclotides special for drug design?

Their circular backbone with knotted disulfide bonds makes them extraordinarily stable. This study proves these features are also essential for antimicrobial activity, meaning stability and function come as a package.

Could cyclotides replace antibiotics?

They're being explored as alternatives. Their unique structure makes them resistant to bacterial defense mechanisms, and their stability means they could potentially be taken orally — addressing two major challenges in antimicrobial peptide development.

Read the original research

An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.

Proceedings of the National Academy of Sciences of the United States of America, 96(16), 8913-8

View on PubMed ↗

Citation

Tam, J P; Lu, Y A; Yang, J L; Chiu, K W. (1999). An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.. Proceedings of the National Academy of Sciences of the United States of America, 96(16), 8913-8.